Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation

Critical Care

Volumn 16, Issue 5, 2012, Pages

  Shekar, Kiran ^a   Roberts, Jason A ^a   Mcdonald, Charles I ^a   Fisquet, Stephanie ^a   Barnett, Adrian G ^b   Mullany, Daniel V ^a   Ghassabian, Sussan ^a   Wallis, Steven C ^a   Fung, Yoke L ^a   Smith, Maree T ^a   Fraser, John F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; CASPOFUNGIN; CEFTRIAXONE; CIPROFLOXACIN; DEXMEDETOMIDINE; FENTANYL; FLUCONAZOLE; HEPARIN; LINEZOLID; MEROPENEM; MIDAZOLAM; MORPHINE; POLYVINYLCHLORIDE; PROPOFOL; SEDATIVE AGENT; THIOPENTAL; VANCOMYCIN;

ARTICLE; BLOOD SAMPLING; CLINICAL PROTOCOL; CONTROLLED STUDY; CRYSTALLOID; DRUG STABILITY; EX VIVO STUDY; EXTRACORPOREAL OXYGENATION; PH; PHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TEMPERATURE; TREATMENT FAILURE; VALIDATION PROCESS;

EID: 84867352649     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11679     Document Type: Article

References (30)

1. Bartlett RH, Gattinoni L. Current status of extracorporeal life support (ECMO) for cardiopulmonary failure. Minerva Anestesiol 2010, 76:534-540.
2. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000, 31(Suppl 4):S131-138.
3. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474. 10.1378/chest.115.2.462, 10027448.
4. Roberts JA, Kruger P, Paterson DL, Lipman J. Antibiotic resistance--what's dosing got to do with it?. Crit Care Med 2008, 36:2433-2440. 10.1097/CCM.0b013e318180fe62, 18596628.
5. Roberts JA, Roberts MS, Semark A, Udy AA, Kirkpatrick CM, Paterson DL, Roberts MJ, Kruger P, Lipman J. Antibiotic dosing in the 'at risk' critically ill patient: linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients. BMC Anesthesiol 2011, 11:3. 10.1186/1471-2253-11-3, 3050838, 21333028.
6. Patel SB, Kress JP. Sedation and analgesia in the mechanically ventilated patient. Am J Respir Crit Care Med 2012, 185:486-497. 10.1164/rccm.201102-0273CI, 22016443.
7. MacLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med 2012, 38:210-220. 10.1007/s00134-011-2439-2, 22147116.
8. Shekar K, Mullany DV, Corley A, Bull T, Fisquet S, Barnett AG, Roberts JA, Fraser JF. Increased sedation requirements in patients receiving extracorporeal life support for respiratory and cardio-respiratory failure. Anaesth Intensive Care 2012, 40:648-655.
9. Shekar K, Roberts JA, Ghassabian S, Mullany DV, Ziegenfuss M, Smith MT, Fung YL, Fraser JF. Sedation during extracorporeal membrane oxygenation -why more is less. Anaesth Intensive Care
10. Bhatt-Meht V, Annich G. Sedative clearance during extracorporeal membrane oxygenation. Perfusion 2005, 20:309-315. 10.1191/0267659105pf827oa, 16363315.
11. Shekar K, Fraser JF, Smith MT, Roberts JA. Pharmacokinetic changes in patients receiving extrcorporeal membrane oxygenation. J Crit Care 2012,
12. Buck ML. Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates. Clin Pharmacokinet 2003, 42:403-417. 10.2165/00003088-200342050-00001, 12739981.
13. Wildschut ED, Ahsman MJ, Allegaert K, Mathot RA, Tibboel D. Determinants of drug absorption in different ECMO circuits. Intensive Care Med 2010, 36:2109-2116. 10.1007/s00134-010-2041-z, 2981740, 20862453.
14. Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009, 37:840-851. quiz 859, 10.1097/CCM.0b013e3181961bff, 19237886.
15. Alcorn J, McNamara PJ. Pharmacokinetics in the newborn. Adv Drug Deliv Rev 2003, 55:667-686. 10.1016/S0169-409X(03)00030-9, 12706549.
16. Shekar K, Fung YL, Diab S, Mullany DV, McDonald CI, Dunster KR, Fisquet S, Platts DG, Stewart D, Wallis SC, Smith MT, Roberts JA, Fraser JF. Development of simulated and ovine models of ECLS to improve understanding of circuit-host interactions. Crit Care Resusc 2012, 14:105-111.
17. Ghassabian S, Moosavi SM, Valero YG, Shekar K, Fraser JF, Smith MT. High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2012, 903:126-133.
18. R Development Core Team R: a language and environment for statistical computing, reference index version 2.13.2. 2010, Vienna, Austria: R Foundation for Statistical Computing, ISBN 3-900051-07-0, R Development Core Team., http://www.R-project.org
19. Varghese JM, Roberts JA, Lipman J. Pharmacokinetics and pharmacodynamics in critically ill patients. Curr Opin Anaesthesiol 2010, 23:472-478. 10.1097/ACO.0b013e328339ef0a, 20489605.
20. Shekar K, Roberts JA, Ghassabian S, Mullany DV, Wallis SC, Smith MT, Fraser JF. Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern?. J Antimicrob Chemother
21. Berthoin K, Le Duff CS, Marchand-Brynaert J, Carryn S, Tulkens PM. Stability of meropenem and doripenem solutions for administration by continuous infusion. J Antimicrob Chemother 2010, 65:1073. 10.1093/jac/dkq044, 20176578.
22. Mulla H, Pooboni S. Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation. Br J Clin Pharmacol 2005, 60:265-275. 10.1111/j.1365-2125.2005.02432.x, 1884778, 16120065.
23. Amaker RD, DiPiro JT, Bhatia J. Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. Antimicrob Agents Chemother 1996, 40:1139-1142. 163279, 8723454.
24. Ahsman MJ, Hanekamp M, Wildschut ED, Tibboel D, Mathot RA. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates. Clin Pharmacokinet 2010, 49:407-419. 10.2165/11319970-000000000-00000, 20481651.
25. Peters JW, Anderson BJ, Simons SH, Uges DR, Tibboel D. Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates. Clin Pharmacokinet 2006, 45:705-714. 10.2165/00003088-200645070-00005, 16802851.
26. Mulla H, Lawson G, von Anrep C, Burke MD, Upton DU, Firmin RK, Killer H. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Perfusion 2000, 15:21-26.
27. Mehta NM, Halwick DR, Dodson BL, Thompson JE, Arnold JH. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Intensive Care Med 2007, 33:1018-1024. 10.1007/s00134-007-0606-2, 17404709.
28. Dagan O, Klein J, Gruenwald C, Bohn D, Barker G, Koren G. Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs. Ther Drug Monit 1993, 15:263-266. 10.1097/00007691-199308000-00001, 8236359.
29. Lipman J, Udy AA, Roberts JA. Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story. Anaesth Intensive Care 2011, 39:999-1000.
30. Ulldemolins M, Roberts JA, Lipman J, Rello J. Antibiotic dosing in multiple organ dysfunction syndrome. Chest 2011, 139:1210-1220. 10.1378/chest.10-2371, 21540219.